Otitis media

Last updated
Otitis media
Other namesOtitis media with effusion: serous otitis media, secretory otitis media
Otitis media entdifferenziert2.jpg
A bulging tympanic membrane which is typical in a case of acute otitis media
Specialty Otorhinolaryngology
Symptoms Ear pain, fever, hearing loss [1] [2]
TypesAcute otitis media, otitis media with effusion, chronic suppurative otitis media [3] [4]
CausesViral, bacterial [4]
Risk factors Smoke exposure, daycare [4]
PreventionVaccination, breastfeeding [1]
Medication Paracetamol (acetaminophen), ibuprofen, benzocaine ear drops [1]
Frequency471 million (2015) [5]
Deaths3,200 (2015) [6]

Otitis media is a group of inflammatory diseases of the middle ear. [2] One of the two main types is acute otitis media (AOM), [3] an infection of rapid onset that usually presents with ear pain. [1] In young children this may result in pulling at the ear, increased crying, and poor sleep. [1] Decreased eating and a fever may also be present. [1] The other main type is otitis media with effusion (OME), typically not associated with symptoms, [1] although occasionally a feeling of fullness is described; [4] it is defined as the presence of non-infectious fluid in the middle ear which may persist for weeks or months often after an episode of acute otitis media. [4] Chronic suppurative otitis media (CSOM) is middle ear inflammation that results in a perforated tympanic membrane with discharge from the ear for more than six weeks. [7] It may be a complication of acute otitis media. [4] Pain is rarely present. [4] All three types of otitis media may be associated with hearing loss. [2] [3] If children with hearing loss due to OME do not learn sign language, it may affect their ability to learn. [8]

Contents

The cause of AOM is related to childhood anatomy and immune function. [4] Either bacteria or viruses may be involved. [4] Risk factors include exposure to smoke, use of pacifiers, and attending daycare. [4] It occurs more commonly among indigenous Australians and those who have cleft lip and palate or Down syndrome. [4] [9] OME frequently occurs following AOM and may be related to viral upper respiratory infections, irritants such as smoke, or allergies. [3] [4] Looking at the eardrum is important for making the correct diagnosis. [10] Signs of AOM include bulging or a lack of movement of the tympanic membrane from a puff of air. [1] [11] New discharge not related to otitis externa also indicates the diagnosis. [1]

A number of measures decrease the risk of otitis media including pneumococcal and influenza vaccination, breastfeeding, and avoiding tobacco smoke. [1] The use of pain medications for AOM is important. [1] This may include paracetamol (acetaminophen), ibuprofen, benzocaine ear drops, or opioids. [1] In AOM, antibiotics may speed recovery but may result in side effects. [12] Antibiotics are often recommended in those with severe disease or under two years old. [11] In those with less severe disease they may only be recommended in those who do not improve after two or three days. [11] The initial antibiotic of choice is typically amoxicillin. [1] In those with frequent infections tympanostomy tubes may decrease recurrence. [1] In children with otitis media with effusion antibiotics may increase resolution of symptoms, but may cause diarrhoea, vomiting and skin rash. [13]

Worldwide AOM affects about 11% of people a year (about 325 to 710 million cases). [14] [15] Half the cases involve children less than five years of age and it is more common among males. [4] [14] Of those affected about 4.8% or 31 million develop chronic suppurative otitis media. [14] The total number of people with CSOM is estimated at 65–330 million people. [16] Before the age of ten OME affects about 80% of children at some point. [4] Otitis media resulted in 3,200 deaths in 2015 – down from 4,900 deaths in 1990. [6] [17]

Signs and symptoms

Otitis media Otitis Media.png
Otitis media

The primary symptom of acute otitis media is ear pain; other possible symptoms include fever, reduced hearing during periods of illness, tenderness on touch of the skin above the ear, purulent discharge from the ears, irritability, ear blocking sensation and diarrhea (in infants). Since an episode of otitis media is usually precipitated by an upper respiratory tract infection (URTI), there are often accompanying symptoms like a cough and nasal discharge. [1] One might also experience a feeling of fullness in the ear.

Discharge from the ear can be caused by acute otitis media with perforation of the eardrum, chronic suppurative otitis media, tympanostomy tube otorrhea, or acute otitis externa. Trauma, such as a basilar skull fracture, can also lead to cerebrospinal fluid otorrhea (discharge of CSF from the ear) due to cerebral spinal drainage from the brain and its covering (meninges).[ citation needed ]

Causes

The common cause of all forms of otitis media is dysfunction of the Eustachian tube. [18] This is usually due to inflammation of the mucous membranes in the nasopharynx, which can be caused by a viral upper respiratory tract infection (URTI), strep throat, or possibly by allergies. [19]

By reflux or aspiration of unwanted secretions from the nasopharynx into the normally sterile middle-ear space, the fluid may then become infected – usually with bacteria. The virus that caused the initial upper respiratory infection can itself be identified as the pathogen causing the infection. [19]

Diagnosis

Perforation of the right tympanic membrane resulting from previous severe acute otitis media Subtotal Perforation of the right tympanic membrane.tif
Perforation of the right tympanic membrane resulting from previous severe acute otitis media

As its typical symptoms overlap with other conditions, such as acute external otitis, symptoms alone are not sufficient to predict whether acute otitis media is present; it has to be complemented by visualization of the tympanic membrane. [20] [21] Examiners may use a pneumatic otoscope with a rubber bulb attached to assess the mobility of the tympanic membrane. Other methods to diagnose otitis media is with a tympanometry, reflectometry, or hearing test.

In more severe cases, such as those with associated hearing loss or high fever, audiometry, tympanogram, temporal bone CT and MRI can be used to assess for associated complications, such as mastoid effusion, subperiosteal abscess formation, bony destruction, venous thrombosis or meningitis. [22]

Acute otitis media in children with moderate to severe bulging of the tympanic membrane or new onset of otorrhea (drainage) is not due to external otitis. Also, the diagnosis may be made in children who have mild bulging of the ear drum and recent onset of ear pain (less than 48 hours) or intense erythema (redness) of the ear drum.

To confirm the diagnosis, middle-ear effusion and inflammation of the eardrum (called myringitis or tympanitis) have to be identified; signs of these are fullness, bulging, cloudiness and redness of the eardrum. [1] It is important to attempt to differentiate between acute otitis media and otitis media with effusion (OME), as antibiotics are not recommended for OME. [1] It has been suggested that bulging of the tympanic membrane is the best sign to differentiate AOM from OME, with a bulging of the membrane suggesting AOM rather than OME. [23]

Viral otitis may result in blisters on the external side of the tympanic membrane, which is called bullous myringitis (myringa being Latin for "eardrum"). [24]

However, sometimes even examination of the eardrum may not be able to confirm the diagnosis, especially if the canal is small. If wax in the ear canal obscures a clear view of the eardrum it should be removed using a blunt cerumen curette or a wire loop. Also, an upset young child's crying can cause the eardrum to look inflamed due to distension of the small blood vessels on it, mimicking the redness associated with otitis media.

Acute otitis media

The most common bacteria isolated from the middle ear in AOM are Streptococcus pneumoniae, Haemophilus influenzae , Moraxella catarrhalis, [1] and Staphylococcus aureus . [25]

Otitis media with effusion

Otitis media with effusion (OME), also known as serous otitis media (SOM) or secretory otitis media (SOM), and colloquially referred to as 'glue ear,' [26] is fluid accumulation that can occur in the middle ear and mastoid air cells due to negative pressure produced by dysfunction of the Eustachian tube. This can be associated with a viral upper respiratory infection (URI) or bacterial infection such as otitis media. [27] An effusion can cause conductive hearing loss if it interferes with the transmission of vibrations of middle ear bones to the vestibulocochlear nerve complex that are created by sound waves. [28]

Early-onset OME is associated with feeding of infants while lying down, early entry into group child care, parental smoking, lack or too short a period of breastfeeding, and greater amounts of time spent in group child care, particularly those with a large number of children. These risk factors increase the incidence and duration of OME during the first two years of life. [29]

Chronic suppurative otitis media

Chronic suppurative otitis media (CSOM) is a chronic inflammation of the middle ear and mastoid cavity that is characterised by discharge from the middle ear through a perforated tympanic membrane for at least 6 weeks. CSOM occurs following an upper respiratory tract infection that has led to acute otitis media. This progresses to a prolonged inflammatory response causing mucosal (middle ear) oedema, ulceration and perforation. The middle ear attempts to resolve this ulceration by production of granulation tissue and polyp formation. This can lead to increased discharge and failure to arrest the inflammation, and to development of CSOM, which is also often associated with cholesteatoma. There may be enough pus that it drains to the outside of the ear (otorrhea), or the pus may be minimal enough to be seen only on examination with an otoscope or binocular microscope. Hearing impairment often accompanies this disease. People are at increased risk of developing CSOM when they have poor eustachian tube function, a history of multiple episodes of acute otitis media, live in crowded conditions, and attend paediatric day care facilities. Those with craniofacial malformations such as cleft lip and palate, Down syndrome, and microcephaly are at higher risk.[ citation needed ]

Worldwide approximately 11% of the human population is affected by AOM every year, or 709 million cases. [14] [15] About 4.4% of the population develop CSOM. [15]

According to the World Health Organization, CSOM is a primary cause of hearing loss in children. [30] Adults with recurrent episodes of CSOM have a higher risk of developing permanent conductive and sensorineural hearing loss.

In Britain, 0.9% of children and 0.5% of adults have CSOM, with no difference between the sexes. [30] The incidence of CSOM across the world varies dramatically where high income countries have a relatively low prevalence while in low income countries the prevalence may be up to three times as great. [14] Each year 21,000 people worldwide die due to complications of CSOM. [30]

Adhesive otitis media

Adhesive otitis media occurs when a thin retracted ear drum becomes sucked into the middle-ear space and stuck (i.e., adherent) to the ossicles and other bones of the middle ear.

Prevention

AOM is far less common in breastfed infants than in formula-fed infants, [31] and the greatest protection is associated with exclusive breastfeeding (no formula use) for the first six months of life. [1] A longer duration of breastfeeding is correlated with a longer protective effect. [31]

Pneumococcal conjugate vaccines (PCV) in early infancy decrease the risk of acute otitis media in healthy infants. [32] PCV is recommended for all children, and, if implemented broadly, PCV would have a significant public health benefit. [1] Influenza vaccination in children appears to reduce rates of AOM by 4% and the use of antibiotics by 11% over 6 months. [33] However, the vaccine resulted in increased adverse-effects such as fever and runny nose. [33] The small reduction in AOM may not justify the side effects and inconvenience of influenza vaccination every year for this purpose alone. [33] PCV does not appear to decrease the risk of otitis media when given to high-risk infants or for older children who have previously experienced otitis media. [32]

Risk factors such as season, allergy predisposition and presence of older siblings are known to be determinants of recurrent otitis media and persistent middle-ear effusions (MEE). [34] History of recurrence, environmental exposure to tobacco smoke, use of daycare, and lack of breastfeeding have all been associated with increased risk of development, recurrence, and persistent MEE. [35] [36] Pacifier use has been associated with more frequent episodes of AOM. [37]

Long-term antibiotics, while they decrease rates of infection during treatment, have an unknown effect on long-term outcomes such as hearing loss. [38] This method of prevention has been associated with emergence of undesirable antibiotic-resistant otitic bacteria. [1]

There is moderate evidence that the sugar substitute xylitol may reduce infection rates in healthy children who go to daycare. [39]

Evidence does not support zinc supplementation as an effort to reduce otitis rates except maybe in those with severe malnutrition such as marasmus. [40]

Probiotics do not show evidence of preventing acute otitis media in children. [41]

Management

Oral and topical pain killers are the mainstay for the treatment of pain caused by otitis media. Oral agents include ibuprofen, paracetamol (acetaminophen), and opiates. A 2023 review found evidence for the effectiveness of single or combinations of oral pain relief in acute otitis media is lacking. [42] Topical agents shown to be effective include antipyrine and benzocaine ear drops. [43] Decongestants and antihistamines, either nasal or oral, are not recommended due to the lack of benefit and concerns regarding side effects. [44] Half of cases of ear pain in children resolve without treatment in three days and 90% resolve in seven or eight days. [45] The use of steroids is not supported by the evidence for acute otitis media. [46] [47]

Antibiotics

Use of antibiotics for acute otitis media has benefits and harms. As over 82% of acute episodes settle without treatment, about 20 children must be treated to prevent one case of ear pain, 33 children to prevent one perforation, and 11 children to prevent one opposite-side ear infection. For every 14 children treated with antibiotics, one child has an episode of vomiting, diarrhea or a rash. [48] Analgesics may relieve pain, if present. For people requiring surgery to treat otitis media with effusion, preventative antibiotics may not help reduce the risk of post-surgical complications. [49]

For bilateral acute otitis media in infants younger than 24 months, there is evidence that the benefits of antibiotics outweigh the harms. [12] A 2015 Cochrane review concluded that watchful waiting is the preferred approach for children over six months with non severe acute otitis media. [12]

Most children older than 6 months of age who have acute otitis media do not benefit from treatment with antibiotics. If antibiotics are used, a narrow-spectrum antibiotic like amoxicillin is generally recommended, as broad-spectrum antibiotics may be associated with more adverse events. [1] [50] If there is resistance or use of amoxicillin in the last 30 days then amoxicillin-clavulanate or another penicillin derivative plus beta lactamase inhibitor is recommended. [1] Taking amoxicillin once a day may be as effective as twice [51] or three times a day. While less than 7 days of antibiotics have fewer side effects, more than seven days appear to be more effective. [52] If there is no improvement after 2–3 days of treatment a change in therapy may be considered. [1] Azithromycin appears to have less side effects than either high dose amoxicillin or amoxicillin/clavulanate. [53]

Tympanostomy tube

Tympanostomy tubes (also called "grommets") are recommended with three or more episodes of acute otitis media in 6 months or four or more in a year, with at least one episode or more attacks in the preceding 6 months. [1] There is tentative evidence that children with recurrent acute otitis media (AOM) who receive tubes have a modest improvement in the number of further AOM episodes (around one fewer episode at six months and less of an improvement at 12 months following the tubes being inserted). [54] [55] Evidence does not support an effect on long-term hearing or language development. [55] [56] A common complication of having a tympanostomy tube is otorrhea, which is a discharge from the ear. [57] The risk of persistent tympanic membrane perforation after children have grommets inserted may be low. [54] It is still uncertain whether or not grommets are more effective than a course of antibiotics. [54]

Oral antibiotics should not be used to treat uncomplicated acute tympanostomy tube otorrhea. [57] They are not sufficient for the bacteria that cause this condition and have side effects including increased risk of opportunistic infection. [57] In contrast, topical antibiotic eardrops are useful. [57]

Otitis media with effusion

The decision to treat is usually made after a combination of physical exam and laboratory diagnosis, with additional testing including audiometry, tympanogram, temporal bone CT and MRI. [58] [59] [60] Decongestants, [61] glucocorticoids, [62] and topical antibiotics are generally not effective as treatment for non-infectious, or serous, causes of mastoid effusion. [58] Moreover, it is recommended against using antihistamines and decongestants in children with OME. [61] In less severe cases or those without significant hearing impairment, the effusion can resolve spontaneously or with more conservative measures such as autoinflation. [63] [64] In more severe cases, tympanostomy tubes can be inserted, [56] possibly with adjuvant adenoidectomy [58] as it shows a significant benefit as far as the resolution of middle ear effusion in children with OME is concerned. [65]

Chronic suppurative otitis media

Topical antibiotics are of uncertain benefit as of 2020. [66] Some evidence suggests that topical antibiotics may be useful either alone or with antibiotics by mouth. [66] Antiseptics are of unclear effect. [67] Topical antibiotics (quinolones) are probably better at resolving ear discharge than antiseptics. [68]

Alternative medicine

Complementary and alternative medicine is not recommended for otitis media with effusion because there is no evidence of benefit. [27] Homeopathic treatments have not been proven to be effective for acute otitis media in a study with children. [69] An osteopathic manipulation technique called the Galbreath technique [70] was evaluated in one randomized controlled clinical trial; one reviewer concluded that it was promising, but a 2010 evidence report found the evidence inconclusive. [71]

Outcomes

Disability-adjusted life year for otitis media per 100,000 inhabitants in 2004.
.mw-parser-output .col-begin{border-collapse:collapse;padding:0;color:inherit;width:100%;border:0;margin:0}.mw-parser-output .col-begin-small{font-size:90%}.mw-parser-output .col-break{vertical-align:top;text-align:left}.mw-parser-output .col-break-2{width:50%}.mw-parser-output .col-break-3{width:33.3%}.mw-parser-output .col-break-4{width:25%}.mw-parser-output .col-break-5{width:20%}@media(max-width:720px){.mw-parser-output .col-begin,.mw-parser-output .col-begin>tbody,.mw-parser-output .col-begin>tbody>tr,.mw-parser-output .col-begin>tbody>tr>td{display:block!important;width:100%!important}.mw-parser-output .col-break{padding-left:0!important}}
.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}
no data
< 10
10-14
14-18
18-22
22-26
26-30
30-34
34-38
38-42
42-46
46-50
> 50 Otitis media world map - DALY - WHO2004.svg
Disability-adjusted life year for otitis media per 100,000 inhabitants in 2004.
Deaths from otitis media per million persons in 2012
.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}
0
1
2-4 Otitis media world map-Deaths per million persons-WHO2012.svg
Deaths from otitis media per million persons in 2012
  0
  1
  2–4

Complications of acute otitis media consists of perforation of the ear drum, infection of the mastoid space behind the ear (mastoiditis), and more rarely intracranial complications can occur, such as bacterial meningitis, brain abscess, or dural sinus thrombosis. [72] It is estimated that each year 21,000 people die due to complications of otitis media. [14]

Membrane rupture

In severe or untreated cases, the tympanic membrane may perforate, allowing the pus in the middle-ear space to drain into the ear canal. If there is enough, this drainage may be obvious. Even though the perforation of the tympanic membrane suggests a highly painful and traumatic process, it is almost always associated with a dramatic relief of pressure and pain. In a simple case of acute otitis media in an otherwise healthy person, the body's defenses are likely to resolve the infection and the ear drum nearly always heals. An option for severe acute otitis media in which analgesics are not controlling ear pain is to perform a tympanocentesis, i.e., needle aspiration through the tympanic membrane to relieve the ear pain and to identify the causative organism(s).

Hearing loss

Children with recurrent episodes of acute otitis media and those with otitis media with effusion or chronic suppurative otitis media have higher risks of developing conductive and sensorineural hearing loss. Globally approximately 141 million people have mild hearing loss due to otitis media (2.1% of the population). [73] This is more common in males (2.3%) than females (1.8%). [73]

This hearing loss is mainly due to fluid in the middle ear or rupture of the tympanic membrane. Prolonged duration of otitis media is associated with ossicular complications and, together with persistent tympanic membrane perforation, contributes to the severity of the disease and hearing loss. When a cholesteatoma or granulation tissue is present in the middle ear, the degree of hearing loss and ossicular destruction is even greater. [74]

Periods of conductive hearing loss from otitis media may have a detrimental effect on speech development in children. [75] [76] [77] Some studies have linked otitis media to learning problems, attention disorders, and problems with social adaptation. [78] Furthermore, it has been demonstrated that individuals with otitis media have more depression/anxiety-related disorders compared to individuals with normal hearing. [79] Once the infections resolve and hearing thresholds return to normal, childhood otitis media may still cause minor and irreversible damage to the middle ear and cochlea. [80] More research on the importance of screening all children under 4 years old for otitis media with effusion needs to be performed. [76]

Epidemiology

Acute otitis media is very common in childhood. It is the most common condition for which medical care is provided in children under five years of age in the US. [19] Acute otitis media affects 11% of people each year (709 million cases) with half occurring in those below five years. [14] Chronic suppurative otitis media affects about 5% or 31 million of these cases with 22.6% of cases occurring annually under the age of five years. [14] Otitis media resulted in 2,400 deaths in 2013 down from 4,900 deaths in 1990. [17]

Australian Aboriginals experience a high level of conductive hearing loss largely due to the massive incidence of middle ear disease among the young in Aboriginal communities. Aboriginal children experience middle ear disease for two and a half years on average during childhood compared with three months for non indigenous children. If untreated it can leave a permanent legacy of hearing loss. [81] The higher incidence of deafness in turn contributes to poor social, educational and emotional outcomes for the children concerned. Such children as they grow into adults are also more likely to experience employment difficulties and find themselves caught up in the criminal justice system. Research in 2012 revealed that nine out of ten Aboriginal prison inmates in the Northern Territory suffer from significant hearing loss. [82] Andrew Butcher speculates that the lack of fricatives and the unusual segmental inventories of Australian languages may be due to the very high presence of otitis media ear infections and resulting hearing loss in their populations. People with hearing loss often have trouble distinguishing different vowels and hearing fricatives and voicing contrasts. Australian Aboriginal languages thus seem to show similarities to the speech of people with hearing loss, and avoid those sounds and distinctions which are difficult for people with early childhood hearing loss to perceive. At the same time, Australian languages make full use of those distinctions, namely place of articulation distinctions, which people with otitis media-caused hearing loss can perceive more easily. [83] This hypothesis has been challenged on historical, comparative, statistical, and medical grounds. [84]

Etymology

The term otitis media is composed of otitis, Ancient Greek for "inflammation of the ear", and media, Latin for "middle".

Related Research Articles

<span class="mw-page-title-main">Sinusitis</span> An inflammation of the mucous membrane that lines the sinuses resulting in symptoms

Sinusitis, also known as rhinosinusitis, is an inflammation of the mucous membranes that line the sinuses resulting in symptoms that may include thick nasal mucus, a plugged nose, and facial pain.

<span class="mw-page-title-main">Urinary tract infection</span> Infection that affects part of the urinary tract

A urinary tract infection (UTI) is an infection that affects a part of the urinary tract. When it affects the lower urinary tract it is known as a bladder infection (cystitis) and when it affects the upper urinary tract it is known as a kidney infection (pyelonephritis). Symptoms from a lower urinary tract infection include pain with urination, frequent urination, and feeling the need to urinate despite having an empty bladder. Symptoms of a kidney infection include fever and flank pain usually in addition to the symptoms of a lower UTI. Rarely the urine may appear bloody. In the very old and the very young, symptoms may be vague or non-specific.

<span class="mw-page-title-main">Asthma</span> Long-term inflammatory disease of the airways of the lungs

Asthma is a long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These may occur a few times a day or a few times per week. Depending on the person, asthma symptoms may become worse at night or with exercise.

<span class="mw-page-title-main">Pneumonia</span> Inflammation of the alveoli of the lungs

Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. Symptoms typically include some combination of productive or dry cough, chest pain, fever, and difficulty breathing. The severity of the condition is variable.

<span class="mw-page-title-main">Common cold</span> Common viral infection of the upper respiratory tract

The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. Signs and symptoms may appear fewer than two days after exposure to the virus. These may include coughing, sore throat, runny nose, sneezing, headache, and fever. People usually recover in seven to ten days, but some symptoms may last up to three weeks. Occasionally, those with other health problems may develop pneumonia.

<span class="mw-page-title-main">Pharyngitis</span> Inflammation of the back of the throat

Pharyngitis is inflammation of the back of the throat, known as the pharynx. It typically results in a sore throat and fever. Other symptoms may include a runny nose, cough, headache, difficulty swallowing, swollen lymph nodes, and a hoarse voice. Symptoms usually last 3–5 days, but can be longer depending on cause. Complications can include sinusitis and acute otitis media. Pharyngitis is a type of upper respiratory tract infection.

<span class="mw-page-title-main">Sore throat</span> Medical condition

Sore throat, also known as throat pain, is pain or irritation of the throat. Usually, causes of sore throat include:

<span class="mw-page-title-main">Bronchiolitis</span> Blockage of the small airways in the lungs due to a viral infection

Bronchiolitis is inflammation of the small airways in the lungs. Acute bronchiolitis is due to a viral infection usually affecting children younger than two years of age. Symptoms may include fever, cough, runny nose, wheezing, and breathing problems. More severe cases may be associated with nasal flaring, grunting, or the skin between the ribs pulling in with breathing. If the child has not been able to feed properly, signs of dehydration may be present.

<span class="mw-page-title-main">Peripheral neuropathy</span> Nervous system disease affecting nerves beyond the brain and spinal cord

Peripheral neuropathy, often shortened to neuropathy, refers to damage or disease affecting the nerves. Damage to nerves may impair sensation, movement, gland function, and/or organ function depending on which nerves are affected. Neuropathies affecting motor, sensory, or autonomic nerves result in different symptoms. More than one type of nerve may be affected simultaneously. Peripheral neuropathy may be acute or chronic, and may be reversible or permanent.

<span class="mw-page-title-main">Upper respiratory tract infection</span> Medical condition

An upper respiratory tract infection (URTI) is an illness caused by an acute infection, which involves the upper respiratory tract, including the nose, sinuses, pharynx, larynx or trachea. This commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the common cold. Most infections are viral in nature, and in other instances, the cause is bacterial. URTIs can also be fungal or helminthic in origin, but these are less common.

<span class="mw-page-title-main">Lower respiratory tract infection</span> Medical term

Lower respiratory tract infection (LRTI) is a term often used as a synonym for pneumonia but can also be applied to other types of infection including lung abscess and acute bronchitis. Symptoms include shortness of breath, weakness, fever, coughing and fatigue. A routine chest X-ray is not always necessary for people who have symptoms of a lower respiratory tract infection.

<span class="mw-page-title-main">Conductive hearing loss</span> Medical condition

Conductive hearing loss (CHL) occurs when there is a problem transferring sound waves anywhere along the pathway through the outer ear, tympanic membrane (eardrum), or middle ear (ossicles). If a conductive hearing loss occurs in conjunction with a sensorineural hearing loss, it is referred to as a mixed hearing loss. Depending upon the severity and nature of the conductive loss, this type of hearing impairment can often be treated with surgical intervention or pharmaceuticals to partially or, in some cases, fully restore hearing acuity to within normal range. However, cases of permanent or chronic conductive hearing loss may require other treatment modalities such as hearing aid devices to improve detection of sound and speech perception.

A myringotomy is a surgical procedure in which an incision is created in the eardrum to relieve pressure caused by excessive buildup of fluid, or to drain pus from the middle ear. A tympanostomy tube may be inserted through the eardrum to keep the middle ear aerated for a prolonged time and to prevent reaccumulation of fluid. Without the insertion of a tube, the incision usually heals spontaneously within two to three weeks. Depending on the type, the tube is either naturally extruded in 6 to 12 months or removed during a minor procedure.

<span class="mw-page-title-main">Ear pain</span> Pain in the ear

Ear pain, also known as earache or otalgia, is pain in the ear. Primary ear pain is pain that originates from the ear. Secondary ear pain is a type of referred pain, meaning that the source of the pain differs from the location where the pain is felt.

<span class="mw-page-title-main">Tympanostomy tube</span> Medical device inserted into the eardrum

Tympanostomy tube, also known as a grommet,myringotomy tube, or pressure equalizing tube, is a small tube inserted into the eardrum via a surgical procedure called myringotomy to keep the middle ear aerated for a prolonged period of time, typically to prevent accumulation of fluid in the middle ear. The tube itself is made in a variety of designs, most often shaped like a grommet for short-term use, or with long flanges and sometimes resembling a T-shape for long-term use. Materials used to manufacture the tubes are often made from fluoroplastic or silicone, which have largely replaced the use of metal tubes made from stainless steel, titanium, or gold.

<span class="mw-page-title-main">Otitis</span> Medical condition

Otitis is a general term for inflammation in ear or ear infection, inner ear infection, middle ear infection of the ear, in both humans and other animals. When infection is present, it may be viral or bacterial. When inflammation is present due to fluid build up in the middle ear and infection is not present it is considered Otitis media with effusion. It is subdivided into the following:

<span class="mw-page-title-main">Respiratory tract infection</span> Infectious disease affecting nose, throat and lungs

Respiratory tract infections (RTIs) are infectious diseases involving the lower or upper respiratory tract. An infection of this type usually is further classified as an upper respiratory tract infection or a lower respiratory tract infection. Lower respiratory infections, such as pneumonia, tend to be far more severe than upper respiratory infections, such as the common cold.

Otomycosis is a fungal ear infection, a superficial mycotic infection of the outer ear canal caused by micro-organisms called fungi which are related to yeast and mushrooms. It is more common in tropical or warm countries. The infection may be either subacute or acute and is characterized by itching in the ear, malodorous discharge, inflammation, pruritus, scaling, and severe discomfort or ear pain. The mycosis results in inflammation, superficial epithelial exfoliation, masses of debris containing hyphae, suppuration, and pain. Otomycosis can also cause hearing loss.

<span class="mw-page-title-main">Tympanosclerosis</span> Medical condition

Tympanosclerosis is a condition caused by hyalinization and subsequent calcification of subepithelial connective tissue of the tympanic membrane and middle ear, sometimes resulting in a detrimental effect to hearing.

<span class="mw-page-title-main">Tympanic membrane retraction</span> Medical condition

Tympanic membrane retraction describes a condition in which a part of the eardrum lies deeper within the ear than its normal position.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. (March 2013). "The diagnosis and management of acute otitis media". Pediatrics. 131 (3): e964–999. doi: 10.1542/peds.2012-3488 . PMID   23439909.
  2. 1 2 3 Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M (January 2014). "Update on otitis media – prevention and treatment". Infection and Drug Resistance. 7: 15–24. doi: 10.2147/IDR.S39637 . PMC   3894142 . PMID   24453496.
  3. 1 2 3 4 "Ear Infections". cdc.gov. September 30, 2013. Archived from the original on 19 February 2015. Retrieved 14 February 2015.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Minovi A, Dazert S (2014). "Diseases of the middle ear in childhood". GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery. 13: Doc11. doi:10.3205/cto000114. PMC   4273172 . PMID   25587371.
  5. Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC   5055577 . PMID   27733282.
  6. 1 2 Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC   5388903 . PMID   27733281.
  7. Emmett SD, Kokesh J, Kaylie D (November 2018). "Chronic Ear Disease". The Medical Clinics of North America. 102 (6): 1063–1079. doi:10.1016/j.mcna.2018.06.008. PMID   30342609. S2CID   53045631.
  8. Ruben RJ, Schwartz R (February 1999). "Necessity versus sufficiency: the role of input in language acquisition". International Journal of Pediatric Otorhinolaryngology. 47 (2): 137–140. doi:10.1016/S0165-5876(98)00132-3. PMID   10206361. Archived from the original on 2018-06-14. Retrieved 2021-09-27.
  9. "Ear disease in Aboriginal and Torres Strait Islander children" (PDF). AIHW. Archived from the original (PDF) on 17 February 2017. Retrieved 12 May 2017.
  10. Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG, et al. (November 2010). "Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review". JAMA. 304 (19): 2161–2169. doi: 10.1001/jama.2010.1651 . PMID   21081729.
  11. 1 2 3 "Otitis Media: Physician Information Sheet (Pediatrics)". cdc.gov. November 4, 2013. Archived from the original on 10 September 2015. Retrieved 14 February 2015.
  12. 1 2 3 4 Venekamp RP, Sanders SL, Glasziou PP, Rovers MM (2023-11-15). "Antibiotics for acute otitis media in children". The Cochrane Database of Systematic Reviews. 11 (11): CD000219. doi:10.1002/14651858.CD000219.pub5. ISSN   1469-493X. PMC  10646935. PMID   37965923.
  13. Venekamp RP, Burton MJ, van Dongen TM, van der Heijden GJ, van Zon A, Schilder AG (June 2016). "Antibiotics for otitis media with effusion in children". The Cochrane Database of Systematic Reviews. 2016 (6): CD009163. doi:10.1002/14651858.CD009163.pub3. PMC   7117560 . PMID   27290722.
  14. 1 2 3 4 5 6 7 8 Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, et al. (2012). "Burden of disease caused by otitis media: systematic review and global estimates". PLOS ONE. 7 (4): e36226. Bibcode:2012PLoSO...736226M. doi: 10.1371/journal.pone.0036226 . PMC   3340347 . PMID   22558393.
  15. 1 2 3 Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC   4561509 . PMID   26063472.
  16. Erasmus T (2012-09-17). "Chronic suppurative otitis media". Continuing Medical Education. 30 (9): 335–336–336. ISSN   2078-5143. Archived from the original on 2020-10-20. Retrieved 2019-08-07.
  17. 1 2 GBD 2013 Mortality Causes of Death Collaborators (January 2015). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–171. doi:10.1016/S0140-6736(14)61682-2. PMC   4340604 . PMID   25530442.{{cite journal}}: |author1= has generic name (help)CS1 maint: numeric names: authors list (link)
  18. Bluestone CD (2005). Eustachian tube: structure, function, role in otitis media. Hamilton, London: BC Decker. pp. 1–219. ISBN   978-1-55009-066-6.
  19. 1 2 3 Donaldson JD. "Acute Otitis Media". Medscape. Archived from the original on 28 March 2013. Retrieved 17 March 2013.
  20. Laine MK, Tähtinen PA, Ruuskanen O, Huovinen P, Ruohola A (May 2010). "Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age". Pediatrics. 125 (5): e1154–61. doi:10.1542/peds.2009-2689. PMID   20368317. S2CID   709374.
  21. Shaikh N, Hoberman A, Kaleida PH, Ploof DL, Paradise JL (May 2010). "Videos in clinical medicine. Diagnosing otitis media – otoscopy and cerumen removal". The New England Journal of Medicine. 362 (20): e62. doi:10.1056/NEJMvcm0904397. PMID   20484393.
  22. Patel MM, Eisenberg L, Witsell D, Schulz KA (October 2008). "Assessment of acute otitis externa and otitis media with effusion performance measures in otolaryngology practices". Otolaryngology–Head and Neck Surgery. 139 (4): 490–494. doi:10.1016/j.otohns.2008.07.030. PMID   18922333. S2CID   24036039.
  23. Shaikh N, Hoberman A, Rockette HE, Kurs-Lasky M (March 28, 2012). "Development of an algorithm for the diagnosis of otitis media" (PDF). Academic Pediatrics (Submitted manuscript). 12 (3): 214–218. doi:10.1016/j.acap.2012.01.007. PMID   22459064. Archived (PDF) from the original on October 26, 2020. Retrieved November 3, 2018.
  24. Roberts DB (April 1980). "The etiology of bullous myringitis and the role of mycoplasmas in ear disease: a review". Pediatrics. 65 (4): 761–766. doi:10.1542/peds.65.4.761. PMID   7367083. S2CID   31536385.
  25. Benninger MS (March 2008). "Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine". Otolaryngology–Head and Neck Surgery. 138 (3): 274–278. doi:10.1016/j.otohns.2007.11.011. PMID   18312870. S2CID   207300175.
  26. "Glue Ear". NHS Choices. Department of Health. Archived from the original on 13 November 2012. Retrieved 3 November 2012.
  27. 1 2 Rosenfeld RM, Culpepper L, Yawn B, Mahoney MC (June 2004). "Otitis media with effusion clinical practice guideline". American Family Physician. 69 (12): 2776, 2778–2779. PMID   15222643.
  28. "Otitis media with effusion: MedlinePlus Medical Encyclopedia". U.S. National Library of Medicine. Archived from the original on 17 February 2017. Retrieved 17 February 2017.
  29. Owen MJ, Baldwin CD, Swank PR, Pannu AK, Johnson DL, Howie VM (November 1993). "Relation of infant feeding practices, cigarette smoke exposure, and group child care to the onset and duration of otitis media with effusion in the first two years of life". The Journal of Pediatrics. 123 (5): 702–711. doi:10.1016/S0022-3476(05)80843-1. PMID   8229477.
  30. 1 2 3 Acuin J, WHO Dept. of Child and Adolescent Health and Development, WHO Programme for the Prevention of Blindness and Deafness (2004). Chronic suppurative otitis media : burden of illness and management options. Geneve: World Health Organization. hdl:10665/42941. ISBN   978-92-4-159158-4.
  31. 1 2 Lawrence R (2016). Breastfeeding : a guide for the medical profession, 8th edition. Philadelphia, PA: Elsevier. pp. 216–217. ISBN   978-0-323-35776-0.
  32. 1 2 Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, et al. (28 May 2019). "Pneumococcal conjugate vaccines for preventing acute otitis media in children". The Cochrane Database of Systematic Reviews. 5 (5): CD001480. doi:10.1002/14651858.CD001480.pub5. ISSN   1469-493X. PMC   6537667 . PMID   31135969.
  33. 1 2 3 Norhayati MN, Ho JJ, Azman MY (October 2017). "Influenza vaccines for preventing acute otitis media in infants and children". The Cochrane Database of Systematic Reviews. 2017 (10): CD010089. doi:10.1002/14651858.CD010089.pub3. PMC   6485791 . PMID   29039160.
  34. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM (February 2004). "Otitis media". Lancet. 363 (9407): 465–473. doi:10.1016/S0140-6736(04)15495-0. PMID   14962529. S2CID   30439271.
  35. Pukander J, Luotonen J, Timonen M, Karma P (1985). "Risk factors affecting the occurrence of acute otitis media among 2–3-year-old urban children". Acta Oto-Laryngologica. 100 (3–4): 260–265. doi:10.3109/00016488509104788. PMID   4061076.
  36. Etzel RA (February 1987). "Smoke and ear effusions". Pediatrics. 79 (2): 309–311. doi:10.1542/peds.79.2.309a. PMID   3808812. S2CID   1350590.
  37. Rovers MM, Numans ME, Langenbach E, Grobbee DE, Verheij TJ, Schilder AG (August 2008). "Is pacifier use a risk factor for acute otitis media? A dynamic cohort study". Family Practice. 25 (4): 233–236. doi: 10.1093/fampra/cmn030 . PMID   18562333.
  38. Leach AJ, Morris PS (October 2006). Leach AJ (ed.). "Antibiotics for the prevention of acute and chronic suppurative otitis media in children". The Cochrane Database of Systematic Reviews (4): CD004401. doi:10.1002/14651858.CD004401.pub2. PMID   17054203.
  39. Azarpazhooh A, Lawrence HP, Shah PS (August 2016). "Xylitol for preventing acute otitis media in children up to 12 years of age". The Cochrane Database of Systematic Reviews. 2016 (8): CD007095. doi:10.1002/14651858.CD007095.pub3. PMC   8485974 . PMID   27486835. Open Access logo PLoS transparent.svg
  40. Gulani A, Sachdev HS (June 2014). "Zinc supplements for preventing otitis media". The Cochrane Database of Systematic Reviews. 2014 (6): CD006639. doi:10.1002/14651858.CD006639.pub4. PMC   9392835 . PMID   24974096.
  41. Scott AM, Clark J, Julien B, Islam F, Roos K, Grimwood K, et al. (18 June 2019). "Probiotics for preventing acute otitis media in children". Cochrane Database of Systematic Reviews. 2019 (6): CD012941. doi:10.1002/14651858.CD012941.pub2. PMC   6580359 . PMID   31210358.
  42. de Sévaux J, Damoiseaux RA, van de Pol AC, Lutje V, Hay AD, Little P, et al. (18 August 2023). "Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children". The Cochrane Database of Systematic Reviews. 2023 (8): CD011534. doi:10.1002/14651858.CD011534.pub3. PMC  10436353. PMID   37594020.
  43. Sattout A (February 2008). "Best evidence topic reports. Bet 1. The role of topical analgesia in acute otitis media". Emergency Medicine Journal. 25 (2): 103–4. doi:10.1136/emj.2007.056648. PMID   18212148. S2CID   34753900.
  44. Coleman C, Moore M (July 2008). Coleman C (ed.). "Decongestants and antihistamines for acute otitis media in children". The Cochrane Database of Systematic Reviews (3): CD001727. doi:10.1002/14651858.CD001727.pub4. PMID   18646076. (Retracted, see doi:10.1002/14651858.cd001727.pub5 . If this is an intentional citation to a retracted paper, please replace {{ Retracted }} with {{ Retracted |intentional=yes}}.)
  45. Thompson M, Vodicka TA, Blair PS, Buckley DI, Heneghan C, Hay AD (December 2013). "Duration of symptoms of respiratory tract infections in children: systematic review". BMJ. 347: f7027. doi:10.1136/bmj.f7027. PMC   3898587 . PMID   24335668.
  46. Principi N, Bianchini S, Baggi E, Esposito S (February 2013). "No evidence for the effectiveness of systemic corticosteroids in acute pharyngitis, community-acquired pneumonia and acute otitis media". European Journal of Clinical Microbiology & Infectious Diseases. 32 (2): 151–60. doi:10.1007/s10096-012-1747-y. PMC   7087613 . PMID   22993127.
  47. Ranakusuma RW, Pitoyo Y, Safitri ED, Thorning S, Beller EM, Sastroasmoro S, et al. (March 2018). "Systemic corticosteroids for acute otitis media in children" (PDF). The Cochrane Database of Systematic Reviews. 2018 (3): CD012289. doi:10.1002/14651858.CD012289.pub2. PMC   6492450 . PMID   29543327. Archived (PDF) from the original on 2020-10-30. Retrieved 2019-12-16.
  48. Venekamp RP, Sanders SL, Glasziou PP, Rovers MM (2023-11-15). "Antibiotics for acute otitis media in children". The Cochrane Database of Systematic Reviews. 11 (11): CD000219. doi:10.1002/14651858.CD000219.pub5. ISSN   1469-493X. PMC  10646935. PMID   37965923.
  49. Verschuur HP, de Wever WW, van Benthem PP (2004). "Antibiotic prophylaxis in clean and clean-contaminated ear surgery". The Cochrane Database of Systematic Reviews. 2010 (3): CD003996. doi:10.1002/14651858.CD003996.pub2. PMC   9037065 . PMID   15266512.
  50. Coon ER, Quinonez RA, Morgan DJ, Dhruva SS, Ho T, Money N, et al. (April 2019). "2018 Update on Pediatric Medical Overuse: A Review". JAMA Pediatrics. 173 (4): 379–384. doi:10.1001/jamapediatrics.2018.5550. PMID   30776069. S2CID   73495617.
  51. Thanaviratananich S, Laopaiboon M, Vatanasapt P (December 2013). "Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media". The Cochrane Database of Systematic Reviews. 12 (12): CD004975. doi:10.1002/14651858.CD004975.pub3. PMC   10960641 . PMID   24338106.
  52. Kozyrskyj A, Klassen TP, Moffatt M, Harvey K (September 2010). "Short-course antibiotics for acute otitis media". The Cochrane Database of Systematic Reviews. 2010 (9): CD001095. doi:10.1002/14651858.CD001095.pub2. PMC   7052812 . PMID   20824827.
  53. Hum SW, Shaikh KJ, Musa SS, Shaikh N (December 2019). "Adverse Events of Antibiotics Used to Treat Acute Otitis Media in Children: A Systematic Meta-Analysis". The Journal of Pediatrics. 215: 139–143.e7. doi:10.1016/j.jpeds.2019.08.043. PMID   31561959. S2CID   203580952.
  54. 1 2 3 Venekamp RP, Mick P, Schilder AG, Nunez DA (May 2018). "Grommets (ventilation tubes) for recurrent acute otitis media in children". The Cochrane Database of Systematic Reviews. 5 (6): CD012017. doi:10.1002/14651858.CD012017.pub2. PMC   6494623 . PMID   29741289.
  55. 1 2 Steele DW, Adam GP, Di M, Halladay CH, Balk EM, Trikalinos TA (June 2017). "Effectiveness of Tympanostomy Tubes for Otitis Media: A Meta-analysis". Pediatrics. 139 (6): e20170125. doi: 10.1542/peds.2017-0125 . PMID   28562283.
  56. 1 2 Browning GG, Rovers MM, Williamson I, Lous J, Burton MJ (October 2010). "Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children". The Cochrane Database of Systematic Reviews (10): CD001801. doi:10.1002/14651858.CD001801.pub3. PMID   20927726. S2CID   43568574.
  57. 1 2 3 4 American Academy of Otolaryngology–Head and Neck Surgery, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation , American Academy of Otolaryngology–Head and Neck Surgery, archived (PDF) from the original on May 13, 2015, retrieved August 1, 2013, which cites
  58. 1 2 3 Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, et al. (February 2016). "Clinical Practice Guideline: Otitis Media with Effusion (Update)". Otolaryngology–Head and Neck Surgery. 154 (1 Suppl): S1–S41. doi: 10.1177/0194599815623467 . PMID   26832942. S2CID   33459167. Archived from the original on 2019-03-06. Retrieved 2019-03-05.
  59. Wallace IF, Berkman ND, Lohr KN, Harrison MF, Kimple AJ, Steiner MJ (February 2014). "Surgical treatments for otitis media with effusion: a systematic review". Pediatrics. 133 (2): 296–311. doi:10.1542/peds.2013-3228. PMID   24394689. S2CID   2355197.
  60. Rosenfeld RM, Schwartz SR, Pynnonen MA, Tunkel DE, Hussey HM, Fichera JS, et al. (July 2013). "Clinical practice guideline: Tympanostomy tubes in children". Otolaryngology–Head and Neck Surgery. 149 (1 Suppl): S1-35. doi: 10.1177/0194599813487302 . PMID   23818543.
  61. 1 2 Griffin G, Flynn CA (September 2011). "Antihistamines and/or decongestants for otitis media with effusion (OME) in children". The Cochrane Database of Systematic Reviews. 2011 (9): CD003423. doi:10.1002/14651858.CD003423.pub3. PMC   7170417 . PMID   21901683.
  62. Simpson SA, Lewis R, van der Voort J, Butler CC (May 2011). "Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children". The Cochrane Database of Systematic Reviews. 2011 (5): CD001935. doi:10.1002/14651858.CD001935.pub3. PMC   9829244 . PMID   21563132.
  63. Blanshard JD, Maw AR, Bawden R (June 1993). "Conservative treatment of otitis media with effusion by autoinflation of the middle ear". Clinical Otolaryngology and Allied Sciences. 18 (3): 188–92. doi:10.1111/j.1365-2273.1993.tb00827.x. PMID   8365006.
  64. Perera R, Glasziou PP, Heneghan CJ, McLellan J, Williamson I (May 2013). "Autoinflation for hearing loss associated with otitis media with effusion". The Cochrane Database of Systematic Reviews (5): CD006285. doi: 10.1002/14651858.CD006285.pub2 . PMID   23728660.
  65. van den Aardweg MT, Schilder AG, Herkert E, Boonacker CW, Rovers MM (January 2010). "Adenoidectomy for otitis media in children". The Cochrane Database of Systematic Reviews (1): CD007810. doi:10.1002/14651858.CD007810.pub2. PMID   20091650.
  66. 1 2 Brennan-Jones CG, Head K, Chong LY, Burton MJ, Schilder AG, Bhutta MF, et al. (Cochrane ENT Group) (January 2020). "Topical antibiotics for chronic suppurative otitis media". The Cochrane Database of Systematic Reviews. 1 (1): CD013051. doi:10.1002/14651858.CD013051.pub2. PMC   6956124 . PMID   31896168.
  67. Head K, Chong LY, Bhutta MF, Morris PS, Vijayasekaran S, Burton MJ, et al. (January 2020). Cochrane ENT Group (ed.). "Topical antiseptics for chronic suppurative otitis media". The Cochrane Database of Systematic Reviews. 1 (1): CD013055. doi:10.1002/14651858.CD013055.pub2. PMC   6956662 . PMID   31902140.
  68. Head K, Chong LY, Bhutta MF, Morris PS, Vijayasekaran S, Burton MJ, et al. (Cochrane ENT Group) (January 2020). "Antibiotics versus topical antiseptics for chronic suppurative otitis media". The Cochrane Database of Systematic Reviews. 1 (11): CD013056. doi:10.1002/14651858.CD013056.pub2. PMC   6956626 . PMID   31902139.
  69. Jacobs J, Springer DA, Crothers D (February 2001). "Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial". The Pediatric Infectious Disease Journal. 20 (2): 177–183. doi:10.1097/00006454-200102000-00012. PMID   11224838.
  70. Pratt-Harrington D (October 2000). "Galbreath technique: a manipulative treatment for otitis media revisited". The Journal of the American Osteopathic Association. 100 (10): 635–9. doi:10.7556/jaoa.2000.100.10.635 (inactive 2024-03-21). PMID   11105452. S2CID   245177279. Archived from the original on 2023-05-24. Retrieved 2023-05-24.{{cite journal}}: CS1 maint: DOI inactive as of March 2024 (link)
  71. Bronfort G, Haas M, Evans R, Leininger B, Triano J (February 2010). "Effectiveness of manual therapies: the UK evidence report". Chiropractic & Osteopathy. 18 (1): 3. doi: 10.1186/1746-1340-18-3 . PMC   2841070 . PMID   20184717.
  72. Jung TT, Alper CM, Hellstrom SO, Hunter LL, Casselbrant ML, Groth A, et al. (April 2013). "Panel 8: Complications and sequelae". Otolaryngology–Head and Neck Surgery. 148 (4 Suppl): E122–143. doi:10.1177/0194599812467425. PMID   23536529. S2CID   206466859.
  73. 1 2 Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. (December 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMC   6350784 . PMID   23245607.
  74. da Costa SS, Rosito LP, Dornelles C (February 2009). "Sensorineural hearing loss in patients with chronic otitis media". European Archives of Oto-Rhino-Laryngology. 266 (2): 221–4. doi:10.1007/s00405-008-0739-0. hdl: 10183/125807 . PMID   18629531. S2CID   2932807.
  75. Roberts K (June 1997). "A preliminary account of the effect of otitis media on 15-month-olds' categorization and some implications for early language learning". Journal of Speech, Language, and Hearing Research. 40 (3): 508–18. doi:10.1044/jslhr.4003.508. PMID   9210110.
  76. 1 2 Simpson SA, Thomas CL, van der Linden MK, Macmillan H, van der Wouden JC, Butler C (January 2007). "Identification of children in the first four years of life for early treatment for otitis media with effusion". The Cochrane Database of Systematic Reviews. 2010 (1): CD004163. doi:10.1002/14651858.CD004163.pub2. PMC   8765114 . PMID   17253499.
  77. Macfadyen CA, Acuin JM, Gamble C (2005-10-19). "Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations". The Cochrane Database of Systematic Reviews. 2005 (4): CD004618. doi:10.1002/14651858.CD004618.pub2. ISSN   1469-493X. PMC   6669264 . PMID   16235370.
  78. Bidadi S, Nejadkazem M, Naderpour M (November 2008). "The relationship between chronic otitis media-induced hearing loss and the acquisition of social skills". Otolaryngology–Head and Neck Surgery. 139 (5): 665–70. doi:10.1016/j.otohns.2008.08.004. PMID   18984261. S2CID   37667672.
  79. Gouma P, Mallis A, Daniilidis V, Gouveris H, Armenakis N, Naxakis S (January 2011). "Behavioral trends in young children with conductive hearing loss: a case-control study". European Archives of Oto-Rhino-Laryngology. 268 (1): 63–6. doi:10.1007/s00405-010-1346-4. PMID   20665042. S2CID   24611204.
  80. Yilmaz S, Karasalihoglu AR, Tas A, Yagiz R, Tas M (February 2006). "Otoacoustic emissions in young adults with a history of otitis media". The Journal of Laryngology and Otology. 120 (2): 103–7. doi:10.1017/S0022215105004871. PMID   16359151. S2CID   23668097.
  81. "Damien Howard & Dianne Hampton, "Ear disease and Aboriginal families," Aboriginal and Islander Health Worker Journal, July-August 2006, 30 (4) p.9". Archived from the original on 2023-10-16. Retrieved 2023-09-06.
  82. "Farah Farouque, "Hearing loss hits NT indigenous inmates," The Age, 5 March 2012". 4 March 2012. Archived from the original on 6 September 2023. Retrieved 6 September 2023.
  83. Butcher 2018.
  84. Fergus A (2019). Lend Me Your Ears: Otitis Media and Aboriginal Australian languages (PDF) (BA). Archived (PDF) from the original on 2023-10-10. Retrieved 2023-09-06.